Elias Zerhouni

Last updated on 2017-09-28T09:06+0300.

About this image
License: UNKNOWN

sign

Quotes... Extracted quotes from

Elias Zerhouni said : "EMPOWER-CSCC 1 was initiated in 2016 and has enrolled rapidly, underscoring the serious unmet need in advanced CSCC," External link

finanznachrichten-en Wednesday, December 13, 2017 9:52:00 AM EAT

Elias Zerhouni said : "We aim to advance multi-targeting therapeutic approaches for core disease pathways that have the potential to attack more than one disease at a time or bring improved risk benefit in the treatment of a single disease," External link

finanznachrichten-en Wednesday, December 13, 2017 9:52:00 AM EAT

Elias Zerhouni said : "This is a significant milestone that supports our belief that RNAi therapeutics have the potential to become an innovative new class of medicines for patients with rare genetic diseases," External link

marketwatch Thursday, October 26, 2017 11:19:00 AM EAT

Elias Zerhouni said : "This is a significant milestone that supports our belief that RNAi therapeutics have the potential to become an innovative new class of medicines for patients with rare genetic diseases," External link

marketwatch Thursday, October 26, 2017 4:52:00 AM EAT

Elias Zerhouni said : "This approval of DUPIXENT in Europe demonstrates our approach of bringing innovative new therapies to those living with the highest unmet medical need and today's approval represents an important milestone for people living with moderate-to-severe atopic dermatitis in Europe ," External link

prnewswire Thursday, September 28, 2017 8:46:00 AM EAT

Elias Zerhouni said : "We believe that therapies like dupilumab, which focus on specific molecular pathways such as the Th2 pathway associated with multiple chronic allergic diseases, are important targets for further investigations," External link

prnewswire Monday, September 11, 2017 8:25:00 AM EAT

Elias Zerhouni said : "Sanofi continues to be a pioneer in developing diabetes therapies and in bringing forward new treatment options for the approximately 50 percent of patients whose blood sugar levels remain uncontrolled on daily basal insulin. Soliqua 100/33 is an alternate new approach that can help adults living with type 2 diabetes uncontrolled on basal insulin or lixisenatide to reach their treatment goal," External link

prnewswire Tuesday, November 22, 2016 4:03:00 AM EAT

Elias Zerhouni said ( about Commission ) : "We welcome the CHMP positive opinion for Suliqua and look forward to the final decision of the European Commission (EC), as well as the upcoming U.S. Food and Drug Administration decision," External link

finanznachrichten-en Friday, November 11, 2016 4:14:00 PM EAT

Elias Zerhouni déclaré : «Des prototypes pourraient sortir dans 2 ou 3 ans» External link

tdg Thursday, October 20, 2016 7:30:00 PM EAT

Elias Zerhouni déclaré : «Des prototypes pourraient sortir dans 2 ou 3 ans» External link

24heures Thursday, October 20, 2016 7:20:00 PM EAT

Elias Zerhouni déclaré : «Des prototypes pourraient sortir dans 2 ou 3 ans» External link

lematin-CH Thursday, October 20, 2016 5:13:00 PM EAT

Elias Zerhouni said : "Dupilumab is an innovative first-in-class investigational agent that has shown significant efficacy and a favorable safety profile in two pivotal Phase 3 studies in monotherapy for moderate-to-severe atopic dermatitis, and now in concomitant administration with topical corticosteroids," External link

prnewswire Monday, June 6, 2016 10:08:00 AM EAT

Elias Zerhouni said : "We are pleased by the Advisory Committee's recommendation for approval of this investigational diabetes therapy," External link

4-traders Thursday, June 2, 2016 8:19:00 PM EAT

Elias Zerhouni déclaré : "Nous sommes satisfaits que le comité consultatif recommande l'approbation de ce traitement expérimental dans le diabète" External link

capital-FR Thursday, May 26, 2016 11:28:00 AM EAT

Elias Zerhouni said : "We are pleased by the Advisory Committee's recommendation for approval of this investigational diabetes therapy," External link

finanznachrichten-en Thursday, May 26, 2016 2:43:00 AM EAT

Elias Zerhouni said : "We are pleased by the Advisory Committee's recommendation for approval of this investigational diabetes therapy," External link

prnewswire Thursday, May 26, 2016 2:36:00 AM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

lamontagne Friday, March 20, 2015 6:20:00 PM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

lyonne-republicaine Friday, March 20, 2015 6:10:00 PM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

leparisien Friday, March 20, 2015 4:11:00 PM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

lepopulaire Friday, March 20, 2015 3:00:00 PM EAT

Elias Zerhouni déclaré : «Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse» External link

ledauphine Friday, March 20, 2015 12:56:00 PM EAT



Key Titles and Phrases Count Lang Last Seen
director23.68%EN09/11/201711/09/2017
docteur13.16%FR04/22/201722/04/2017
directeur2.63%FR04/22/201722/04/2017
president15.79%EN04/21/201721/04/2017
chef de la recherche5.26%FR11/22/201622/11/2016
researcher2.63%EN08/13/201613/08/2016
medical researcher2.63%EN08/13/201613/08/2016
président15.79%FR05/26/201626/05/2016
director15.79%PT08/30/201330/08/2013
head2.63%EN06/12/200512/06/2005
Names Lang Count
Elias ZerhouniFR44.44%
Elias ZerhouniEN31.31%
Elias ZerhouniEU16.16%
إلياس زرهونيAR3.03%
Elias A. ZerhouniEN3.03%
Elias ZerhouaniFR2.02%
Elyas ZerhouniFR0.00%
Ilias ZerhouniFR0.00%


 
Show/hide duplicate news articles.
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Wednesday, September 18, 2019

4:32:00 PM EAT

Languages Collapse menu...Expand menu...

Select your languages

af
am
ar
de
en
es
fr
ha
pt
rw
sw
all
Show additional languagesHide additional languages

Interface:

Legend Collapse menu...Expand menu...


Quotes... Explore Relations


EMM Visual Explorer


AfricaBrief

Elias Zerhouni

Last updated on 2017-09-28T09:06+0300.

About this image
License: UNKNOWN

sign

Quotes... Extracted quotes from

Elias Zerhouni said : "EMPOWER-CSCC 1 was initiated in 2016 and has enrolled rapidly, underscoring the serious unmet need in advanced CSCC," External link

finanznachrichten-en Wednesday, December 13, 2017 9:52:00 AM EAT

Elias Zerhouni said : "We aim to advance multi-targeting therapeutic approaches for core disease pathways that have the potential to attack more than one disease at a time or bring improved risk benefit in the treatment of a single disease," External link

finanznachrichten-en Wednesday, December 13, 2017 9:52:00 AM EAT

Elias Zerhouni said : "This is a significant milestone that supports our belief that RNAi therapeutics have the potential to become an innovative new class of medicines for patients with rare genetic diseases," External link

marketwatch Thursday, October 26, 2017 11:19:00 AM EAT

Elias Zerhouni said : "This is a significant milestone that supports our belief that RNAi therapeutics have the potential to become an innovative new class of medicines for patients with rare genetic diseases," External link

marketwatch Thursday, October 26, 2017 4:52:00 AM EAT

Elias Zerhouni said : "This approval of DUPIXENT in Europe demonstrates our approach of bringing innovative new therapies to those living with the highest unmet medical need and today's approval represents an important milestone for people living with moderate-to-severe atopic dermatitis in Europe ," External link

prnewswire Thursday, September 28, 2017 8:46:00 AM EAT

Elias Zerhouni said : "We believe that therapies like dupilumab, which focus on specific molecular pathways such as the Th2 pathway associated with multiple chronic allergic diseases, are important targets for further investigations," External link

prnewswire Monday, September 11, 2017 8:25:00 AM EAT

Elias Zerhouni said : "Sanofi continues to be a pioneer in developing diabetes therapies and in bringing forward new treatment options for the approximately 50 percent of patients whose blood sugar levels remain uncontrolled on daily basal insulin. Soliqua 100/33 is an alternate new approach that can help adults living with type 2 diabetes uncontrolled on basal insulin or lixisenatide to reach their treatment goal," External link

prnewswire Tuesday, November 22, 2016 4:03:00 AM EAT

Elias Zerhouni said ( about Commission ) : "We welcome the CHMP positive opinion for Suliqua and look forward to the final decision of the European Commission (EC), as well as the upcoming U.S. Food and Drug Administration decision," External link

finanznachrichten-en Friday, November 11, 2016 4:14:00 PM EAT

Elias Zerhouni déclaré : «Des prototypes pourraient sortir dans 2 ou 3 ans» External link

tdg Thursday, October 20, 2016 7:30:00 PM EAT

Elias Zerhouni déclaré : «Des prototypes pourraient sortir dans 2 ou 3 ans» External link

24heures Thursday, October 20, 2016 7:20:00 PM EAT

Elias Zerhouni déclaré : «Des prototypes pourraient sortir dans 2 ou 3 ans» External link

lematin-CH Thursday, October 20, 2016 5:13:00 PM EAT

Elias Zerhouni said : "Dupilumab is an innovative first-in-class investigational agent that has shown significant efficacy and a favorable safety profile in two pivotal Phase 3 studies in monotherapy for moderate-to-severe atopic dermatitis, and now in concomitant administration with topical corticosteroids," External link

prnewswire Monday, June 6, 2016 10:08:00 AM EAT

Elias Zerhouni said : "We are pleased by the Advisory Committee's recommendation for approval of this investigational diabetes therapy," External link

4-traders Thursday, June 2, 2016 8:19:00 PM EAT

Elias Zerhouni déclaré : "Nous sommes satisfaits que le comité consultatif recommande l'approbation de ce traitement expérimental dans le diabète" External link

capital-FR Thursday, May 26, 2016 11:28:00 AM EAT

Elias Zerhouni said : "We are pleased by the Advisory Committee's recommendation for approval of this investigational diabetes therapy," External link

finanznachrichten-en Thursday, May 26, 2016 2:43:00 AM EAT

Elias Zerhouni said : "We are pleased by the Advisory Committee's recommendation for approval of this investigational diabetes therapy," External link

prnewswire Thursday, May 26, 2016 2:36:00 AM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

lamontagne Friday, March 20, 2015 6:20:00 PM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

lyonne-republicaine Friday, March 20, 2015 6:10:00 PM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

leparisien Friday, March 20, 2015 4:11:00 PM EAT

Elias Zerhouni déclaré : "Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse" External link

lepopulaire Friday, March 20, 2015 3:00:00 PM EAT

Elias Zerhouni déclaré : «Je tiens à saluer et à remercier nos collaborateurs sur place pour le travail accompli et leur plein engagement dans ce projet qui représente une véritable opportunité pour le site de Toulouse» External link

ledauphine Friday, March 20, 2015 12:56:00 PM EAT



Key Titles and Phrases Count Lang Last Seen
director23.68%EN09/11/201711/09/2017
docteur13.16%FR04/22/201722/04/2017
directeur2.63%FR04/22/201722/04/2017
president15.79%EN04/21/201721/04/2017
chef de la recherche5.26%FR11/22/201622/11/2016
researcher2.63%EN08/13/201613/08/2016
medical researcher2.63%EN08/13/201613/08/2016
président15.79%FR05/26/201626/05/2016
director15.79%PT08/30/201330/08/2013
head2.63%EN06/12/200512/06/2005
Names Lang Count
Elias ZerhouniFR44.44%
Elias ZerhouniEN31.31%
Elias ZerhouniEU16.16%
إلياس زرهونيAR3.03%
Elias A. ZerhouniEN3.03%
Elias ZerhouaniFR2.02%
Elyas ZerhouniFR0.00%
Ilias ZerhouniFR0.00%


<<10<12345678910>>>10
<<10<12345678910>>>10

Tools

Load latest edition

Wednesday, September 18, 2019

4:32:00 PM EAT


Quotes... Explore Relations


EMM Visual Explorer